Squarepoint
VNRX icon

Squarepoint’s VolitionRx Ltd VNRX Stock Holding History

Squarepoint’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,733
Closed -$34.4K – 5037
2025
Q4 		$34.4K Buy
+6,733
New +$51.1K ﹤0.01% 4147
2025
Q3 		– Sell
-2,910
Closed -$44.2K – 5055
2025
Q2 		$44.2K Sell
2,910
-130
-4% -$1.43K ﹤0.01% 4322
2025
Q1 		$34.7K Buy
+3,040
New +$36.2K ﹤0.01% 4397
2020
Q3 		– Sell
-1,271
Closed -$99K – 2865
2020
Q2 		$99K Buy
+1,271
New +$91.8K ﹤0.01% 2018

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

Squarepoint's VNRX Position: Q1 2026 in Review

Squarepoint sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 6,733 shares — an estimated $34.4K sold.

Squarepoint first reported a position in VNRX in Q2 2020 and held it in 4 quarters. The position peaked at $99K in Q2 2020. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Squarepoint reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 6,733 VolitionRx Ltd shares in Q1 2026, an estimated $34.4K.
  • Squarepoint first reported a position in VolitionRx Ltd in Q2 2020 and held it in 4 quarters.
  • Squarepoint's VolitionRx Ltd position peaked at $99K in Q2 2020.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.